Host Defenses - Adaptive Immunity Flashcards

1
Q

Define immunogen.

A

Substance that can elicit an immune response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Define immunogenicity.

A

Ability of a substance to trigger an immune response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Define antigen.

A

Substance that binds specifically to an antibody or a T-cell receptor (TCR)
- All immunogens are antigens, but not all antigens are immunogens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Define antigenicity.

A

Ability of an antigen to trigger an immune response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe the four factors that influence the immunogenicity of an immunogen.

A
  1. Size
  2. Complexity
  3. Foreignness, the more distant in phylogeny, more immunogenic
  4. Degradability

In descending order of immunogenicity
- Proteins > polysaccharides > lipids > nucleic acids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Define intracellular bacterial pathogen and extracellular bacterial pathogen and give one
example for each type.

A
  • Intracellular bacterial pathogen: lives and replicates inside host cells (L. monocytogenes)
  • Extracellular bacterial pathogen: lives and replicates outside host cells (S. aureus)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Use Fig. 7.7 to describe the MHC class II antigen-presentation pathway for extracellular or
exogenous antigens.

A
  1. APCs phagocytose or
    macropinocytose microbes and engulf them within phagosomes
  2. Phagosomes fuse with lysosomes to form a phagolysosome for degradation of the microbial material into peptides
  3. Vesicles containing the MHC-II-invariant chain complex bud
    off from the ER to fuse with the peptide-containing phagolysosome
  4. The invariant chain disintegrates within the acidic environment, allowing the peptide to load into the
    vacated peptide-binding groove of the MHC class II molecule
  5. Exocytotic vesicles containing pMHC-II are transported to the cell surface for display and recognition by the TCRs of CD4+ T cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Use Fig. 7.7 to describe the MHC class I antigen-presentation pathway for intracellular or endogenous antigens.

A
  1. Ubiquitin covalently attaches to cytoplasmic proteins, marking them for enzymatic degradation by the proteasome
  2. Proteolytic peptide fragments are transported into the endoplasmic
    reticulum by a heterodimer composed TAP-1 or TAP-2 for possible loading into nascent MHC-I complexes
  3. Exocytotic vesicles containing
    pMHC-I are transported to the cell surface for display and recognition by the TCRs of CD8+ T cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Use Fig. 7.15 to describe immunologic memory and explain why a subsequent immune
response to the same pathogen/antigen occurs faster and is more robust.

A
  • Immunologic memory: ability of the adaptive immune system to recall a previous encounter with a microbe and mount an accelerated, enhanced response against it
  • Subsequent immune response is faster/more robust because a reservoir of memory B cells is maintained in the bone marrow (immune system doesn’t have to go through the process of producing antibodies again)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Use Fig. 7.15 to describe what may happen to a previously established immunologic memory for a specific antigen when the antigen has changed its structure.

A

The previously established immunologic memory wouldn’t be useful
- Immune system would have to go through a primary response again.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Use Fig. 7.1 and Table 7.2 as a guide to draw a typical IgG antibody molecule with the major components labeled and to assign one function to the variable region, the Fab fragment, and the Fc fragment.

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Define epitope.

A

Smallest molecular structure recognized by an antibody or a specific receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Define binding specificity.

A

Ability to discriminate different epitopes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Explain the significance of the variable regions and the constant regions found in antibodies.

A
  • Variable regions only interact with their epitope (recognize different epitopes)
  • Constant regions activate the complement system
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

List the five classes of antibodies (Table 7.2).

A
  1. IgM
  2. IgG
  3. IgA
  4. IgD
  5. IgE
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Use Fig. 7.12 to describe the five antibody-mediated host defenses against bacterial infection.

A

A. Agglutination: Recognition of microbial surface epitopes by antibodies causes a cross-linked lattice formation analogous to the equivalence zone of the quantitative precipitin curve
B. Neutralization: Neutralizing antibodies usually recognize microbial epitopes that would normally interact with molecules on the surface of the host cell and prevent such interaction.
C. Antibody binding to microbial epitopes causes a conformational changes in the Fc portion of the antibody molecule –> FcR recognize and bind –> phagocytosis
D. Complement activation: Antibody binding to a microbial surface may initiate the classical pathway of complement activation and trigger complement-mediated lysis and/or the binding of C3b as an opsonin
E. Antibody binding to microbial epitopes causes a conformational alteration in the Fc portion of the antibody molecule –> FcR recognize and bind –> complex triggers NK cells to release perforins and granzymes

17
Q

Explain whether antibody-mediated defense would be effective against intracellular bacterial
pathogens.

A

No, because antibodies don’t have access to intracellular bacterial pathogens

18
Q

Use Fig. 7.13 to describe the steps in the activation of macrophages by CD4+ Th1 cells for
killing intracellular bacteria.

A
  1. Previously activated CD4+ Th1 cells become reactivated upon recognition of antigens in the context of pMHC class II on APCs (phagocytes)
  2. Reactivated Th1 cells secrete cytokines and chemokines that increase MHC class II expression, degradative enzymes, and reactive oxygen species in macrophages
  3. The activated macrophage has increased killing capacity and destroys everything that comes within its “grasp.”
19
Q

Explain why activation of macrophages as shown in Fig. 7.13 can be a double-edged sword.

A

Because the activated macrophages are not “antigen specific,” they can destroy normal tissue along with infected cells

20
Q

Use Fig. 7.14 to describe how cytotoxic T cells attack and kill intracellular bacteria.

A
  1. Activated CD8+ T cells circulate through body tissues as CTLs, scrutinizing the pMHC class I molecules displayed by nucleated cells
  2. On recognition of the appropriate pMHC class I complex, a series of events are initiated by the CTL that ultimately leads to the lysis of the infected “target cell.” Although contact between the CTL and the target cell lasts only a few minutes, the CTL delivers a fatal “kiss of death” to the target cell in the form of perforin granules and granzymes.
  3. The perforin granules polymerize and form pores in the cell, creating an electrolyte imbalance, and through which granzymes enter. Both perforins and granzymes conspire in the demise of the target cell by osmotic lysis and apoptosis, respectively.
21
Q

Define mucosal immunity.

A

Immune responses at the level of mucosal surfaces, usually involving
antibodies (ex. secretory IgA)

22
Q

Define mucosa-associated lymphoid tissue (MALT) and give one specific example.

A

Networks of lymphocytes and dendritic cells deployed under mucosal surfaces and in tissue-specific lymphoid collections (ex. tonsils, Peyer’s patch)

23
Q

Describe steps in an IgA response to bacterial colonization of the gastrointestinal mucosal
surfaces.

A
  1. Secretion, sIgA
    - Dimeric or polymeric
    - Secretory components
    - Receptors (poly-Ig) on basolateral membranes of epithelial cells
    - Endocytosis and exocytosis to the luminal space (transcytosis)
  2. Distribution
    - Mainly in external secretions
    - Breast milk, saliva, tears, and mucus
24
Q

Describe how secretory IgA (sIgA) contributes to the defense of mucosal surfaces against bacterial infection.

A

sIgA binds to bacteria and prevents them from attaching to mucosal epithelial cells

25
Q

Describe the function of M-cells found in gastrointestinal-associated lymphoid tissue (GALT).

A
  • Sample cells/antigens at the luminal membrane
  • Transport them to lymphocytes and macrophages in the lamina propria
26
Q

Describe, step by step, how you would experimentally determine the relative importance of humoral immunity and cellular immunity in host defense against an extracellular bacterial pathogen or an intracellular bacterial pathogen.

A
  1. Get serum from surviving mice
  2. Inject serum into one group of mice
  3. Infect both groups with the pathogen
  4. Serum group should survive
27
Q

Give three examples to illustrate how innate and adaptive defenses work together to clear microbial infection and explain how such a cooperation enhances host resistance (See Table 6.10, Figs. 6.3, 6.5, 7.12).

A
  1. Opsonophagocytosis: antibodies (adaptive) and phagocytes (innate)
  2. ADCC: antibody-dependent cell cytotoxicity (macrophages, NK cells, eosinophils)
  3. Innate immunity initiates adaptive immune respones
28
Q

Reading assignment: Describe the role of natural IgM in complement activation by S. pneumoniae strain D39 (Fig. 2A).

A

IgM mediates C3 binding to S. pneumoniae

29
Q

Reading assignment: Describe the role of natural IgM in host resistance to S. pneumoniae infection (Fig. 2B).

A

IgM increases host resistance to S. pneumoniae